Eli Lilly to shutter European facilities
Eli Lilly plans to shutter two research sites and a manufacturing facility in Europe, including one R&D center in Belgium that employs 330 staffers. Altogether, most of the 900 workers employed at the facilities will be affected by the restructuring. The manufacturing center is at Basingstoke. Lilly said the move was prompted by what it called an increasingly difficult global environment hampered by price pressures.
- here's the AFX report on Lilly
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
